Medical Articles

Immune immunotherapy has improved, with immune checkpoint inhibitors (ICIs) being the most effective. Antitumor responses mediated by ICIs generally depend on T cells capable of recognizing different types of cells.

Nucleotide biosynthesis inhibitors were among the first antitumor agents to be discovered, and they remain the backbone of treatment for many cancer indications. Recently, nucleotide biosynthesis has been “rediscovered” several times as a critical vulnerability of cancer in various genomic screening approaches.

CRISPR is a revolutionary technology in genetic engineering, allowing scientists to edit genes with extreme precision. It has shown promise in treating many diseases, including cancer.

Bone cancer is a heterogeneous group of tumors that can be benign or malignant. Malignant bone cancers, which arise from bone or cartilage, account for approximately 0.2% of malignant tumors. They can be classified into different types, such as osteosarcoma, chondrosarcoma, and Ewing sarcoma, which differ primarily in their histological structure and age of onset.